PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

0.8815

-0.0394 (-4.28%)

At close: Jan 9, 2026, 4:00 PM EST

0.9032

+0.0217 (2.46%)

After-hours: Jan 9, 2026, 7:35 PM EST

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 9, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Market Capitalization	9	9	18	51	48	42	Upgrade
Market Cap Growth	-19.52%	-52.51%	-64.81%	5.50%	14.27%	16.41%	Upgrade
Enterprise Value	-12	-8	-20	-22	-38	39	Upgrade
Last Close Price	0.88	1.24	2.12	2.92	2.33	26.57	Upgrade
PE Ratio	-	0.36	-	-	-	-	Upgrade
PB Ratio	0.17	0.16	0.45	0.70	0.54	6.33	Upgrade
P/TBV Ratio	0.26	0.17	0.69	0.74	0.56	13.50	Upgrade
Debt / Equity Ratio	-	-	-	-	-	0.01	Upgrade
Quick Ratio	13.06	6.60	6.76	115.99	121.24	3.04	Upgrade
Current Ratio	14.60	7.68	6.80	116.18	121.38	3.14	Upgrade
Return on Equity (ROE)	-17.68%	67.08%	0.60%	-5.31%	-8.78%	-60.35%	Upgrade
Return on Assets (ROA)	-4.76%	-4.75%	-6.12%	-4.92%	-5.60%	-33.37%	Upgrade
Return on Capital (ROIC)	-6.60%	-5.99%	-7.26%	-4.96%	-5.68%	-37.71%	Upgrade
Return on Capital Employed (ROCE)	-7.80%	-8.40%	-12.40%	-8.90%	-4.90%	-54.20%	Upgrade
Earnings Yield	-85.45%	360.19%	1.86%	-8.47%	-8.78%	-8.40%	Upgrade
Buyback Yield / Dilution	15.57%	23.50%	50.84%	-25.56%	-971.73%	-60.24%	Upgrade

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q